Epigenetic resensitization to platinum in recurrent, platinum-resistant ovarian cancer (OC) using guadecitabine (SGI-110), a novel hypomethylating agent (HMA): Results of a randomized phase II study.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Matulonis, UA; Oza, AM; Secord, AA; Roman, LD; Blagden, SP; Banerjee, SN; Elkas, JC; Nemunaitis, JJ; Ghamande, SA; Fleming, GF; Markham, MJ; Hirte, HW; Provencher, DM; Basu, B; Kristeleit, RS; Naim, S; Hao, Y; Keer, HN; Azab, M; Matei, D

Published Date

  • May 20, 2016

Published In

Volume / Issue

  • 34 / 15_suppl

Start / End Page

  • 5547 - 5547

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2016.34.15_suppl.5547